Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Details Narrative)

v3.22.2
Cash, Cash Equivalents, Restricted Cash and Marketable Securities (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Cash and Cash Equivalents [Abstract]          
Cash cash equivalents and restricted cash $ 250   $ 250   $ 250
Marketable securities, unrealized loss 125 $ 85 609 $ 177  
Net accumulated unrealized losses $ 754   $ 754   $ 145